Skip to main content

Table 1 Prevalence of enteric pathogens by age and sex demographic group

From: Prevalence and diversity of enteric pathogens among cholera treatment centre patients with acute diarrhea in Uvira, Democratic Republic of Congo

Enteric Pathogen Prevalence (95% Confidence Interval)
Total enrolled Boys 1–15 years Men 16–81 years Girls 1–15 years Women 16–81 years
Total Samples 269 54 83 47 85
At least one pathogen positive 83.6% (78.7–87.6) 85.2% (72.7–92.5) 83.1% (73.3–89.8) 89.4% (76.4–95.6) 80.0% (70.0–87.3)
Bacteria 73.9% (68.4–78.9) 68.5% (54.7–79.7) 75.9% (65.4–84.0) 78.7% (64.4–88.3) 72.9% (62.4–81.4)
Toxigenic Vibrio cholerae 38.3% (32.6–44.3) 25.9% (15.8–39.5) 51.8% (41.0–62.5) 38.3% (25.3–53.2) 32.9% (23.7–43.7)
Enterotoxigenic E. coli 35.7% (30.2–41.6) 40.7% (28.3–54.5) 30.1% (21.1–41.0) 38.3% (25.3–53.2) 36.5% (26.8–47.3)
Campylobacter 16.7% (12.7–21.7) 27.8% (17.3–41.4) 10.8% (5.7–19.7) 29.8% (18.3–44.6) 8.2% (3.9–16.4)
Shigella 16.0% (12.1–20.9) 24.1% (14.3–37.5) 14.5% (8.3–23.9) 23.4% (13.2–37.9) 8.2% (3.9–16.4)
Salmonella 3.7% (2.0–6.8) 3.7% (0.9–14.0) 2.4% (0.6–9.4) 4.3% (1.0–16.0) 4.7% (1.8–12.0)
Escherichia coli O157 2.5% (1.3–5.4) 1.9% (0.2–12.5) 2.5% (0.6–9.5) 6.4% (2.0–18.5) 1.2% (0.1–8.1)
Clostridium difficile 1.9% (0.8–4.4) 1.9% (0.2–12.5) 2.1% (0.3–14.3) 3.5% (1.1–10.5)
Shiga Toxin-producing E. coli 0.7% (0.2–2.9) 2.1% (0.3–14.3) 1.2% (0.02–8.1)
Yersinia enterocolitica
Viruses 2.2% (1.0–4.9) 5.6% (1.8–16.2) 2.1% (0.3–14.3) 2.4% (0.6–9.1)
Adenovirus 40/41 1.1% (0.4–3.4) 1.8% (0.2–12.5) 2.1% (0.3–14.3) 1.2% (0.2–8.1)
Norovirus GI/GII 0.7% (0.2–2.9) 18.5% (0.2–12.5) 1.2% (0.2–8.1)
Rotavirus A 0.4% (0.1–2.6) 1.9% (0.2–12.5)
Parasites 27.5% (22.5–33.2) 35.2% (23.5–49.0) 26.5% (18.0–37.2) 29.8% (18.3–44.6) 22.4% (14.6–32.6)
Cryptosporidium 27.5% (22.5–33.2) 35.2% (23.5–49.0) 26.5% (18.0–37.2) 29.8% (18.3–44.6) 22.4% (14.6–32.6)
Entamoeba histolytica
Pathogen Diversity
No pathogens 16.4% (12.4–21.3) 14.8% (7.5–27.3) 16.9% (10.2–26.7) 10.6% (4.4–23.6) 20.0% (12.7–30.0)
Single pathogen 38.3% (32.6–44.3) 35.2% (23.5–49.0) 41.0% (30.8–52.0) 21.3% (11.6–35.6) 47.1% (36.6–57.8)
2 pathogens 25.6% (20.8–31.2) 18.5% (10.1–31.5) 26.5% (18.0–37.2) 36.2% (23.5–51.1) 23.5% (15.6–33.8)
3 pathogens 14.9% (11.1–19.7) 22.2% (12.9–35.5) 12.0% (6.5–21.1) 23.5% (13.2–37.9) 8.2% (3.9–16.4)
4 pathogens 3.7% (2.0–6.8) 7.4% (2.7–18.5) 3.6% (1.2–10.8) 6.4% (2.0–18.5)
5 pathogens 0.7% (0.2–2.9) 2.1% (0.3–1.4) 1.2% (0.2–8.1)
6 pathogens
7 pathogens
8 pathogens 0.4% (0.1–2.6) 1.9% (0.2–12.5)
\